News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Research News & Stories
Clinical, In the Media, Research
Jessica Silva-Fisher Receives American Cancer Society Grant
WashU Medicine investigator at Siteman Cancer Center aims to study how chemical modifications to RNA contribute to the progression of multiple myeloma Jessica Silva-Fisher, PhD, a WashU Medicine scientist at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has received a Research Scholar Grant from the American Cancer Society (ACS) — one of only […]
Clinical, In the Media, Research
Newly Approved Pancreatic Cancer Treatment Has Been Shown To Prolong Life — And Highlights Siteman’s Role in Bringing Innovation to Patients
FDA approves first-in-class drug trialed at WashU Medicine and Siteman Cancer Center — a new option for patients with metastatic disease Daraxonrasib is a drug that targets RAS proteins, which are mutated in more than 90% of pancreatic cancers. As a clinical trial site, Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine evaluated the […]
Clinical, In the Media, Research
Technique Evaluates Reliability of Imaging Measurements Used in Medical Decision-Making
Method could help clinicians, regulators assess new wave of AI-enabled quantitative imaging products Advances in medical imaging and artificial intelligence (AI) have revolutionized many aspects of medical practice in recent years. Quantitative measurements derived from medical images are increasingly being used to support diagnosis and clinical decision-making. Consequently, many new quantitative imaging tools, including those […]
Clinical, Research
mRNA-Based Therapy Offers New Hope Against High-Risk Melanoma
Siteman Cancer Center served as a major, early clinical trial site for groundbreaking vaccine In a major announcement, an experimental mRNA vaccine has been shown in global clinical trials to prevent melanoma from returning or spreading in high-risk melanoma patients when combined with the immunotherapy drug pembrolizumab, known commercially as Keytruda, and given after surgery. The […]
Research
New Discovery May Point to Clues About How Head and Neck Cancers Spread
WashU Medicine researchers at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, along with colleagues at the Weizmann Institute of Science in Israel, have found that aggressive cancer cells can appear in different locations within head and neck tumors, providing new clues as to why some such cancers — particularly squamous cell carcinomas not caused by […]
In the Media, Research
Laser Therapy Offers Weapon Against Deadly Brain Tumors
Large analysis of patient outcomes shows that extent of tumor ablation, treatment timing extends survival For patients facing a diagnosis of glioblastoma — one of the most aggressive and devastating forms of brain cancer — the standard path forward has long meant an invasive open-skull surgery and a daunting prognosis. Over the past decade and […]
Clinical, Research
Finding Order in the Inner Chaos of our Cells
New technique wrangles evasive proteins to dissect the cause of diseases and design potential new therapeutics The vast majority of proteins in our bodies contain regions that are in a constant state of wiggling, shape-shifting every few nanoseconds to completely change how they look. Information on how these shapeshifting proteins work is critical to understanding […]
In the Media, Research, Staff/Faculty Update
Bergom Named ASTRO Fellow
WashU Medicine radiation oncologist Carmen Bergom, MD, PhD, FACS, a renowned research member of Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has been named a fellow of the American Society for Radiation Oncology (ASTRO). The honor recognizes ASTRO members’ outstanding achievements and contributions to the organization, cancer research, education and patient care. Bergom and other newly named fellows will be recognized at ASTRO’s 68th Annual […]
In the Media, Research, Staff/Faculty Update
Siteman Investment Program Awards $2.24 Million for Cancer Research
Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is pleased to announce $2.24 million in new funding for 11 new projects, including three clinical trials. Through this research, investigators aim to improve the understanding of tumor formation and growth, develop safer, more effective therapies, and remove barriers to precision medicine. The funded projects focus on a variety of […]
Clinical, In the Media, Research
New Approach to Designing Drugs Supercharges Cancer Medication
Shape-shifting drug hits tumors in multiple ways, improves outcomes in mice Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drug, often given to patients for whom standard chemotherapy has not worked. The drugs are precise, but can attack only one kind of target […]